Screening for cardiovascular disease in patients with advanced chronic kidney disease

Rajan Sharma1

  • 1Department of Cardiology, Ealing Hospital NHS Trust, London, UK. heddington@doctors.org.uk

Insights

Cardiovascular disease is a major risk for advanced chronic kidney disease (CKD) patients. This review assesses cardiac diagnostic tools, finding echocardiography and stress tests useful but no single test predicts sudden cardiac death.

Area of Science:

  • Nephrology
  • Cardiology
  • Diagnostic Imaging

Background:

  • Cardiovascular disease (CVD) is the primary cause of death and illness in advanced chronic kidney disease (CKD) and post-renal transplant patients.
  • Identifying patients at high risk for cardiac events is challenging, impacting long-term outcomes for dialysis patients and renal transplant candidate selection.

Purpose of the Study:

  • To evaluate the diagnostic accuracy and prognostic value of various cardiac tests in patients with advanced CKD.
  • To guide the selection of appropriate cardiac investigations for this high-risk population.

Main Methods:

  • Review of current literature on diagnostic cardiac imaging modalities.
  • Analysis of the strengths and limitations of echocardiography, stress echocardiography, myocardial perfusion imaging, and coronary angiography.

Main Results:

  • Echocardiography effectively detects cardiomyopathy and provides prognostic information.
  • Stress echocardiography, myocardial perfusion imaging, and coronary angiography are optimal for assessing coronary artery disease and predict patient outcomes.
  • Currently, no single diagnostic test reliably predicts sudden cardiac death in advanced CKD patients.

Conclusions:

  • Multiple cardiac tests are valuable for risk stratification in advanced CKD patients, but no single gold standard exists.
  • The choice of cardiac testing should consider patient factors, local expertise, and test availability.
  • Further research is needed to identify optimal methods for predicting sudden cardiac death in this population.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...